Guidelines for exercise and physical activity in diabetes management prioritize the reduction of sedentary time, highlighting the importance of incorporating regular physical activity and minimizing prolonged sitting to optimize glycemic control and cardiovascular health.
November 2022
Early identification and management of cardiovascular risk factors are crucial in patients with mental illness to mitigate the heightened cardiovascular risk associated with psychiatric conditions and improve long-term cardiovascular outcomes in this vulnerable population.
November 2022
Chest pain at rest is the most common presenting symptom of acute coronary syndrome, highlighting the importance of timely recognition and diagnostic evaluation to guide appropriate management and improve outcomes in affected individuals.
November 2022
An updated risk algorithm for prostate cancer identifies age as the predominant risk factor, with almost all cases occurring after age 55 years, highlighting the importance of age-stratified screening and early detection efforts in reducing prostate cancer mortality.
November 2022
Post-COVID-19 patients face an increased risk of deep vein thrombosis, highlighting the need for thromboprophylaxis measures and ongoing surveillance to prevent thrombotic complications in individuals recovering from COVID-19 infection.
November 2022
The FDA authorizes the first condom specifically endorsed for anal sex, featuring a special lubricant, aiming to promote safer sexual practices and reduce the risk of sexually transmitted infections, including HIV, among at-risk populations.
November 2022
A study guide is provided for the differential diagnosis and clinical assessment of jaundice, outlining key considerations and diagnostic approaches to guide healthcare practitioners in the evaluation and management of patients presenting with this common clinical symptom.
November 2022
Among more than 3.7 million vaccines administered, 371 cases of shoulder pathology following vaccination are identified, highlighting the importance of surveillance and reporting of vaccine-related adverse events to guide vaccine safety monitoring and risk assessment.
November 2022